A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients

• Main Authors: Joris Mallard (Author), Elyse Hucteau (Author), Laura Bender (Author), Fabien Moinard‐Butot (Author), Emma Rochelle (Author), Lauréline Boutonnet (Author), Antoine Grandperrin (Author), Roland Schott (Author), Carole Pflumio (Author), Philippe Trensz (Author), Michal Kalish‐Weindling (Author), Anne‐Laure Charles (Author), Bernard Gény (Author), Fabrice Favret (Author), Xavier Pivot (Author), Thomas J. Hureau (Author), Allan F. Pagano (Author)
• Format: Book
• Published: Wiley, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Breast cancer patients are commonly treated with sequential administrations of epirubicin-cyclophosphamide (EC) and paclitaxel (TAX). The chronic effect of this treatment induces skeletal muscle alterations, but the specific effect of each chemotherapy agent is unknown. This stud...